Guided Therapeutics GTHP
OTC GTHP
$0.10 -0.01 (-9.09%)
At close: Nov 11, 2026 · 4:00 PM EST

Guided Therapeutics (GTHP) Return on Sales [ROS] (2009 - 2026)

Updated

Guided Therapeutics' Return on Sales [ROS] was -303.85% in Q2 2026, up 348.29 percentage points from -652.14% a year earlier but down 9.19 percentage points from the prior quarter.

Analysis

Guided Therapeutics (GTHP) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For FY2025, Return on Sales [ROS] at Guided Therapeutics came in at -309.26%, up 29805.03 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +722.12 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -30114.29% in FY2024 (-26586.73 pp), -3527.55% in FY2023 (+22110.91 pp), -25638.46% in FY2022 (-22722.41 pp) and -2916.05% in FY2021 (-1884.68 pp).
  • Quarterly Return on Sales [ROS] has moved between -216400.00% (Q1 2025) and -120.34% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has increased for five straight quarters, with an average year-over-year change of +2186.73 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2026 (a gain of 216105.35 percentage points); the worst was Q1 2025 (a drop of 210416.67 percentage points).
  • Per Business Quant data, GTHP's Return on Sales [ROS] in the three quarters before Q2 2026 was -294.65% (Q1 2026), -120.34% (Q4 2025) and -808.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 10.44%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 19.44%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 18.08%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 17.44%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 6.36%
10 Guided Therapeutics 10,618.96 -520,381.04 - -303.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -303.85%
Mar 31, 2026 -294.65%
Dec 31, 2025 -120.34%
Sep 30, 2025 -808.33%
Jun 30, 2025 -652.14%
Mar 31, 2025 -216,400.00%
Dec 31, 2024 -53,400.00%
Sep 30, 2024 -5,421.05%
Jun 30, 2024 -5,584.21%
Mar 31, 2024 -5,983.33%
Dec 31, 2023 -1,515.63%
Sep 30, 2023 -5,937.88%
Jun 30, 2023 -3,420.45%
Mar 31, 2023 -3,831.82%
Dec 31, 2022 -25,630.77%
Sep 30, 2022 -40,800.00%
Jun 30, 2022 -14,340.00%
Mar 31, 2022 -8,860.00%
Dec 31, 2021 -725.00%
Sep 30, 2021 -2,563.16%
API Access

Guided Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GTHP&period=max&api_key=YOUR_API_KEY